CEIBA Investments Limited: €25 million oversubscribed convertible Bond Issue
CEIBA Investments Limited has announced the successful completion of a €25 million, 10%, senior unsecured convertible Bond Issue due for repayment on 31 March 2026. The conversion price of the Bonds is equal to the (unaudited)
Apr
4D pharma completes c.$40 million Merger and Private Placement with Longevity Acquisition Corporation
4D pharma plc is pleased to announce that its business combination with Longevity Acquisition Corporation has now become effective. The NASDAQ dual-listing and private placement has raised almost $40 million for the Company. 4D pharma’s existing
Mar
Tap Issue raising $14.7 million for Tufton Oceanic Assets Limited
N+1 Singer is delighted to have acted as Joint Broker to Tufton Oceanic on a fundraise of US$14.7 million via the issue of 15,000,000 Tap Issue Shares at a price of US$0.98 per Tap Issue Share.
Mar
Oversubscribed Placing raising £9 million for Oncimmune Holdings plc
N+1 Singer is delighted to have supported Oncimmune Holdings plc in its successful oversubscribed Placing. The Placing was enlarged to accommodate additional investor interest from both new and existing investors. The Placing has raised gross proceeds
Mar
AdvancedAdvT Limited raise £130 million
AdvancedAdvT Limited (previously named ‘Marwyn Acquisition Company I Limited’) is pleased to announce a Placing of 94.8 million new Ordinary Shares of no par value in the Company issued at £1 per share and subscriptions by
Mar
N+1 Singer appointed as Nominated Adviser & Sole Broker to Induction Healthcare Group plc
N+1 Singer are delighted to announce its appointment as Nominated Adviser and Sole Broker to Induction Healthcare Group plc with immediate effect. About Induction Healthcare Group plc Induction Healthcare is a UK-based leading healthcare technology company
Mar